Target intelligence / Profile preview

Diverse microbial and endogenous antigens

Molecular classification
Other
01

Overview

Diverse microbial and endogenous antigens represent a broad class of molecules that trigger immune responses by acting as ligands for various receptors. Microbial antigens, or Pathogen-Associated Molecular Patterns (PAMPs), include components like lipopolysaccharides, peptidoglycans, and viral nucleic acids (Janeway et al., 2001). Endogenous antigens, or Damage-Associated Molecular Patterns (DAMPs), are host-derived molecules such as HMGB1 and heat shock proteins released during tissue injury (Kono & Rock, 2008). These antigens are recognized by Pattern Recognition Receptors (PRRs), including Toll-like receptors (TLRs), which initiate the innate immune response and help shape adaptive immunity (Kumar et al., 2011). Because this term encompasses a vast array of chemically distinct molecules rather than a single protein or receptor, it is not considered a specific therapeutic target. Instead, drug development focuses on the receptors that sense these antigens or the specific antigens themselves in the context of vaccine design. Therapeutic strategies involving these antigens often utilize them as adjuvants to boost vaccine efficacy or target their receptors to modulate inflammation. In autoimmune diseases, the immune system inappropriately responds to endogenous antigens, leading to chronic inflammation and tissue damage. Understanding the diversity of these antigens is crucial for developing broad-spectrum anti-infectives and targeted immunotherapies.

Other names
Pathogen-associated molecular patterns (PAMPs)Damage-associated molecular patterns (DAMPs)Microbial antigensEndogenous antigensAutoantigensSelf-antigens
02

Mechanism of action

Activation of pattern recognition receptors (PRRs) and antigen-specific receptors to initiate innate and adaptive immune responses.

03

Biological functions

Immune responseAntigen presentationInflammationOther
04

Disease associations

InfectionInflammationCancerAutoimmune diseaseOther
05

Safety considerations

Cytokine release syndromeSystemic inflammatory response syndromeInduction of autoimmunityInjection site reactions
06

Interacting drugs

Imiquimod

4 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)C-reactive protein (CRP)Antigen-specific antibody titers

Beyond the preview

Go deeper on Diverse microbial and endogenous antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diverse microbial and endogenous antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call